Article Type
Changed
Mon, 10/31/2022 - 16:08

Key clinical point: A gluten-free diet influenced bowel habits and had significant positive effects on irritable bowel syndrome (IBS) symptom severity, abdominal pain intensity, and daily life interference.

 

Major finding: In patients with IBS, the IBS-severity scoring system total score (P = .02), abdominal pain intensity (P = .02), and daily life interference (P = .04) improved significantly after the gluten-free intervention but not after the gluten-containing intervention. Patients with IBS reported fewer loose stools during the gluten-free vs gluten-containing intervention (19.2% vs 27.4%; P = .01).

 

Study details: The data come from a randomized controlled trial (PROT-IBS) including 20 patients with IBS and 21 healthy control individuals who were challenged with gluten (14 g/day) or rice flour during two 14-day interventions, while adhering to a strict gluten-free diet.

 

Disclosures: This study was funded by the Swedish Research Council and other sources. Some authors declared receiving consulting fees or research grants or serving on advisory boards for various sources.

 

Source: Algera JP et al. Randomised controlled trial: Effects of gluten-free diet on symptoms and the gut microenvironment in irritable bowel syndrome. Aliment Pharmacol Ther. 2022;56(9):1318-1327 (Sep 29). Doi: 10.1111/apt.17239

 

Publications
Topics
Sections

Key clinical point: A gluten-free diet influenced bowel habits and had significant positive effects on irritable bowel syndrome (IBS) symptom severity, abdominal pain intensity, and daily life interference.

 

Major finding: In patients with IBS, the IBS-severity scoring system total score (P = .02), abdominal pain intensity (P = .02), and daily life interference (P = .04) improved significantly after the gluten-free intervention but not after the gluten-containing intervention. Patients with IBS reported fewer loose stools during the gluten-free vs gluten-containing intervention (19.2% vs 27.4%; P = .01).

 

Study details: The data come from a randomized controlled trial (PROT-IBS) including 20 patients with IBS and 21 healthy control individuals who were challenged with gluten (14 g/day) or rice flour during two 14-day interventions, while adhering to a strict gluten-free diet.

 

Disclosures: This study was funded by the Swedish Research Council and other sources. Some authors declared receiving consulting fees or research grants or serving on advisory boards for various sources.

 

Source: Algera JP et al. Randomised controlled trial: Effects of gluten-free diet on symptoms and the gut microenvironment in irritable bowel syndrome. Aliment Pharmacol Ther. 2022;56(9):1318-1327 (Sep 29). Doi: 10.1111/apt.17239

 

Key clinical point: A gluten-free diet influenced bowel habits and had significant positive effects on irritable bowel syndrome (IBS) symptom severity, abdominal pain intensity, and daily life interference.

 

Major finding: In patients with IBS, the IBS-severity scoring system total score (P = .02), abdominal pain intensity (P = .02), and daily life interference (P = .04) improved significantly after the gluten-free intervention but not after the gluten-containing intervention. Patients with IBS reported fewer loose stools during the gluten-free vs gluten-containing intervention (19.2% vs 27.4%; P = .01).

 

Study details: The data come from a randomized controlled trial (PROT-IBS) including 20 patients with IBS and 21 healthy control individuals who were challenged with gluten (14 g/day) or rice flour during two 14-day interventions, while adhering to a strict gluten-free diet.

 

Disclosures: This study was funded by the Swedish Research Council and other sources. Some authors declared receiving consulting fees or research grants or serving on advisory boards for various sources.

 

Source: Algera JP et al. Randomised controlled trial: Effects of gluten-free diet on symptoms and the gut microenvironment in irritable bowel syndrome. Aliment Pharmacol Ther. 2022;56(9):1318-1327 (Sep 29). Doi: 10.1111/apt.17239

 

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan: IBS November 2022
Gate On Date
Wed, 06/29/2022 - 14:30
Un-Gate On Date
Wed, 06/29/2022 - 14:30
Use ProPublica
CFC Schedule Remove Status
Wed, 06/29/2022 - 14:30
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article